Comera Life Sciences Holdings (CMRA, $0.03) was a top loser this month, diving -2 to $0.03 per share. Of the 903 stocks analyzed in the Biotechnology Industry throughout this month, of them (5) exhibited an Uptrend while of them (4) were in a Downtrend.